Quotes 5-day view Delayed Nyse
06/17/2022
06/21/2022
06/22/2022
06/23/2022
06/24/2022
Date
130.64(c)
131.93(c)
134.34(c)
137.42(c)
140.31(c)
Last
1 764 487
859 537
850 072
915 275
995 065
Volume
+2.08%
+0.99%
+1.83%
+2.29%
+2.10%
Change
Estimated financial data (e) (USD)
Sales 2022
9 346 M
-
-
Net income 2022
1 058 M
-
-
Net Debt 2022
2 995 M
-
-
P/E ratio 2022
16,4x
Yield 2022
1,83%
Sales 2023
9 092 M
-
-
Net income 2023
946 M
-
-
Net Debt 2023
2 790 M
-
-
P/E ratio 2023
18,3x
Yield 2023
1,93%
Capitalization
16 467 M
16 467 M
-
EV / Sales 2022
2,08x
EV / Sales 2023
2,12x
Nbr of Employees
44 500
Free-Float
71,6%
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (96.8%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (3.2%).
Ratings of Quest Diagnostics
All news about QUEST DIAGNOSTICS
News in other languages on QUEST DIAGNOSTICS
Analyst Recommendations on QUEST DIAGNOSTICS
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends QUEST DIAGNOSTICS
Short Term Mid-Term Long Term Trends Neutral Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
140,31 $
Average target price
148,79 $
Spread / Average Target
6,04%
Please enable JavaScript in your browser's settings to use dynamic charts.